Coherus Oncology CHRS
NASDAQ CHRS
$0.75 +0.00 (+0.23%)
As of: Nov 6, 2026 · 10:07 AM EST

Coherus Oncology (CHRS) Price to Book (2014 - 2026)

Updated

Coherus Oncology's (CHRS) Price to Book stood at 3.55 in Q2 2026, up 402.0% from 0.71 a year earlier and up 7.2% from the prior quarter.

Analysis

Coherus Oncology (CHRS) Price to Book (2014 - 2026) Analysis & Trends

For FY2025, Coherus Oncology's Price to Book came in at 2.82.

  • Across earlier years, Price to Book came in at 12.56 in FY2021 (+180.1%).
  • The Q2 2026 figure is the highest quarterly Price to Book since Q1 2022.
  • Per Business Quant, the preceding three quarters came in at 3.31 (Q1 2026), 2.82 (Q4 2025) and 2.17 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.28 Bn 1,194.89 Bn 20.46 Bn
2 Johnson & Johnson 653.62 Bn 573.48 Bn 17.30 Bn
3 AbbVie 509.01 Bn 477.02 Bn 13.12 Bn
4 Merck 362.31 Bn 325.26 Bn 13.19 Bn
5 Novartis Ag 312.49 Bn 285.73 Bn -
6 Astrazeneca 285.84 Bn 259.73 Bn 13.26 Bn
7 Amgen 248.19 Bn 199.85 Bn 7.58 Bn
8 Gilead Sciences 208.17 Bn 183.27 Bn 6.73 Bn
9 Pfizer 166.64 Bn 114.00 Bn 12.56 Bn
10 Coherus Oncology 116.82 Mn -519.32 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.55
Mar 31, 2026 3.31
Dec 31, 2025 2.82
Sep 30, 2025 2.17
Jun 30, 2025 0.71
Mar 31, 2022 79.47
Dec 31, 2021 12.56
Sep 30, 2021 9.41
Jun 30, 2021 6.77
Mar 31, 2021 8.37
Dec 31, 2020 4.49
Sep 30, 2020 5.17
Jun 30, 2020 5.98
Mar 31, 2020 7.31
Dec 31, 2019 12.04
Sep 30, 2019 25.36
Sep 30, 2018 90.56
Jun 30, 2018 15.36
Dec 31, 2017 17.25
Sep 30, 2017 13.77
API Access

Coherus Oncology Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=CHRS&period=max&api_key=YOUR_API_KEY